“…2,3,4 During the last years our group has in vitro and in silico characterized various types of fully covalently bound truncated octahedral DNA nanocages and studied their behaviour in cells. [5][6][7][8][9][10] DNA nanocages, including octahedral cages, possess many attractive properties for cancer nanotherapy: they are intrinsically nontoxic, with excellent biocompatibility and biodegradability, [11][12][13] are readily internalized by living cells via endocytosis, 10,14 show high resistance to degradation 15,16 and can efficiently intercalate anticancer drugs such as doxorubicin. [17][18][19][20] Doxorubicin (Dox) is one of the most commonly used anticancer agents for the treatment of a wide variety of solid tumours including breast, ovarian, prostate, brain, cervix and lung cancers and haematological malignancies, such as multiple myeloma, several types of leukaemia and lymphomas.…”